Oncology News

Researchers observed an inverse association between diabetes severity and survival outcomes among patients who underwent curative resection for colorectal cancer, according to study results.

MADRID — Sotorasib plus panitumumab prolonged PFS compared with standard of care for patients with chemorefractory KRAS G12C-mutated metastatic colorectal cancer, study results presented at ESMO Congress showed.

The gut microbiome is linked to preexisting colorectal lesions, as well as future development of lesions, according to a presenter at UEG Week, and including microbiome biomarkers may improve noninvasive tests for colorectal cancer.

A computer-aided polyp detection system did not improve adenoma or polyp detection among colorectal cancer screening candidates in an outpatient setting in Germany, according to data presented at UEG Week.

MADRID — Adding pembrolizumab to trastuzumab and chemotherapy extended PFS for patients with unresectable HER2-positive metastatic gastric or gastroesophageal junction adenocarcinoma, study results presented at ESMO Congress showed.

MADRID — Pembrolizumab with chemotherapy before and after surgery increased pathologic complete response among patients with locally advanced gastric or gastroesophageal junction cancer, according to findings presented at ESMO Congress.

An artificial intelligence endoscopy module increased the detection of adenomas, including sessile serrated polyps, during colonoscopy and is recommended for implementation into routine practice, a presenter said at UEG Week.

A cloud-based artificial intelligence system significantly improved adenoma detection, including hard-to-detect lesions in the proximal colon, by non-expert endoscopists in the United Kingdom, according to results presented at UEG week.

Debulking combined with standard systemic therapy did not significantly impact overall quality of life for a cohort of patients with metastatic colorectal cancer, according to study results.

Liver Cancer Awareness Month, celebrated every October, seeks to raise awareness about the third deadliest cancer in the United States, with approximately 41,000 new cases and as many as 30,000 deaths each year.